Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MIRM compared with NAMS: revenue, margins and what each company keeps, and the suppliers and customers both name
MIRM
Mirum Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
NAMS
NewAmsterdam Pharma Co N.V.
Change
Mkt cap
Revenue
Revenue
vs
Compare
MIRM
Mirum Pharmaceuticals, Inc.
vs
NAMS
NewAmsterdam Pharma Co N.V.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
MIRM, solid
NAMS, dashed
Supply-chain overlap
Revenue flow
MIRM: latest quarter is a loss; flow not drawable. NAMS: latest quarter is a loss; flow not drawable.
Method
›
MIRM
Mirum Pharmaceuticals, Inc.
Change
84.76
▼
−1.89%
· post 84.74
Mkt cap
$5.5B
Revenue
$176M
Q2 FY26
Revenue
$521M
FY25
NAMS
NewAmsterdam Pharma Co N.V.
Change
20.05
▼
−3.42%
· post 20.05
Closed
Oct 30 '26
Mkt cap
$2.4B
Revenue
$4M
Q2 FY26
Revenue
$23M
FY25
vs
Compare
Closed
Oct 30 '26
MIRM
Mirum Pharmaceuticals, Inc.
vs
NAMS
NewAmsterdam Pharma Co N.V.
84.76
▼
−1.89%
post 84.74
Price
20.05
▼
−3.42%
post 20.05
$5.5B
Mkt cap
$2.4B
Q2 FY26
$176M
Revenue
$4M
Q2 FY26
FY25
$521M
Revenue
$23M
FY25
Change
Change
MIRM
84.76
▼
−1.89%
vs
NAMS
20.05
▼
−3.42%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only MIRM
14
PFE
Pfizer
supplier
SNYNF
Sanofi-Aventis Deutschland GmbH
supplier
—
Bluejay Therapeutics
unlisted
supplier
—
Dart Neuroscience
unlisted
supplier
10 more · MIRM chain
›
Shared
0
No disclosed counterparties: NAMS.
Only NAMS
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR